Click Here to return To Results

 

Natalizumab Use in Pediatric Multiple Sclerosis Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008 See this aricle in Pubmed Article Abstract Natalizumab treatment was effective and well tolerated in our pediatric patients with RRMS who did not respond to initial immunomodulatory treatments. Therefore, it is a promising second-line therapy for pediatric patients with RRMS.

Related Tags

(click to filter results - removes previous filter) children efficacy immunomodulation monoclonal antibodies multiple sclerosis multiple sclerosis,children multiple sclerosis,relapsing multiple sclerosis,treatment of natalizumab safety treatment of neurologic disorder

Click Here to return To Results